Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 0.26% | 82.48 | 0.7% | $1558.96m | |
| JNJ | Johnson & Johnson | -0.01% | 165.76 | 0.7% | $1044.55m | |
| PFE | Pfizer Inc. | 0.60% | 43.80 | 0.9% | $947.59m | |
| ABBV | AbbVie, Inc. | -0.08% | 109.32 | 1.9% | $659.34m | |
| LLY | Eli Lilly & Co. | 0.51% | 249.74 | 1.1% | $642.36m | |
| BMY | Bristol-Myers Squibb Co. | 0.00% | 58.21 | 1.0% | $634.93m | |
| AZN | AstraZeneca Plc | -0.15% | 62.17 | 1.0% | $284.56m | |
| NVS | Novartis AG | -1.97% | 83.16 | 0.2% | $179.09m | |
| GSK | GlaxoSmithKline Plc | -1.39% | 39.60 | 0.2% | $162.96m | |
| AVIR | Atea Pharmaceuticals, Inc. | -0.08% | 12.38 | 0.3% | $123.37m | |
| RGEN | Repligen Corp. | 0.00% | 273.83 | 6.8% | $109.24m | |
| VTRS | Viatris, Inc. | 0.30% | 13.52 | 0.0% | $89.79m | |
| NVO | Novo Nordisk A/S | -1.33% | 105.95 | 0.1% | $89.64m | |
| SNY | Sanofi | -1.10% | 49.41 | 0.2% | $65.71m | |
| OGN | Organon & Co. | -0.33% | 36.62 | 0.0% | $52.99m |
Company Profile
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.